Efficacy and safety of combined aspirin and warfarin therapy after heart valve replacement: a systematic review and meta-analysis of randomized clinical trials

Aim. To conduct a systematic review and meta-analysis of the efficacy and safety of combined oral anticoagulant therapy with vitamin K antagonists (VKA) and antiplatelet therapy with aspirin compared with VKA monotherapy in patients after mechanical valve replacement.Material and methods. We searche...

Full description

Bibliographic Details
Main Authors: E. Z. Golukhova, B. Sh. Berdibekov, E. V. Ruzina
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2022-09-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/4933
_version_ 1826561019752742912
author E. Z. Golukhova
B. Sh. Berdibekov
E. V. Ruzina
author_facet E. Z. Golukhova
B. Sh. Berdibekov
E. V. Ruzina
author_sort E. Z. Golukhova
collection DOAJ
description Aim. To conduct a systematic review and meta-analysis of the efficacy and safety of combined oral anticoagulant therapy with vitamin K antagonists (VKA) and antiplatelet therapy with aspirin compared with VKA monotherapy in patients after mechanical valve replacement.Material and methods. We searched the PubMed, Google Scholar databases for studies comparing the risk of thromboembolic events, major bleeding, and mortality in VKA monotherapy versus combined aspirin and VKA therapy in patients with mechanical valve replacement.Results. Eight randomized clinical trials were selected for this systematic review and meta-analysis. In total, 4082 patients were included in the analysis (mean age, 50,8 years, men — 2484 (60,9%)). A meta-analysis showed that the addition of aspirin to VKA, compared with VKA monotherapy, significantly reduced the incidence of thromboembolic events (odds ratio (OR) 0,47; 95% confidence interval (CI): 0,33-0,67; p<0,0001) and mortality (OR 0,58; 95% CI: 0,38-0,88; p=0,01). The risk of major bleeding in the aspirin plus VKA group compared with VKA monotherapy tended to increase, without reaching a significant difference (OR 1,41; 95% CI: 0,99-2,01; p=0,06).Conclusion. The addition of aspirin to VKA, compared with VKA monotherapy, reduces the risk of systemic embolism and death in patients after mechanical valve replacement. At the same time, the risk of major bleeding did not differ between the groups.
first_indexed 2024-04-09T20:43:49Z
format Article
id doaj.art-df2b30ce1edb4f91b5461f8c63e3e8ff
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2025-03-14T09:25:31Z
publishDate 2022-09-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-df2b30ce1edb4f91b5461f8c63e3e8ff2025-03-02T11:42:59Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202022-09-01273S10.15829/1560-4071-2022-49333680Efficacy and safety of combined aspirin and warfarin therapy after heart valve replacement: a systematic review and meta-analysis of randomized clinical trialsE. Z. Golukhova0B. Sh. Berdibekov1E. V. Ruzina2A.N. Bakulev National Medical Research Center for Cardiovascular SurgeryA.N. Bakulev National Medical Research Center for Cardiovascular SurgeryA.N. Bakulev National Medical Research Center for Cardiovascular SurgeryAim. To conduct a systematic review and meta-analysis of the efficacy and safety of combined oral anticoagulant therapy with vitamin K antagonists (VKA) and antiplatelet therapy with aspirin compared with VKA monotherapy in patients after mechanical valve replacement.Material and methods. We searched the PubMed, Google Scholar databases for studies comparing the risk of thromboembolic events, major bleeding, and mortality in VKA monotherapy versus combined aspirin and VKA therapy in patients with mechanical valve replacement.Results. Eight randomized clinical trials were selected for this systematic review and meta-analysis. In total, 4082 patients were included in the analysis (mean age, 50,8 years, men — 2484 (60,9%)). A meta-analysis showed that the addition of aspirin to VKA, compared with VKA monotherapy, significantly reduced the incidence of thromboembolic events (odds ratio (OR) 0,47; 95% confidence interval (CI): 0,33-0,67; p<0,0001) and mortality (OR 0,58; 95% CI: 0,38-0,88; p=0,01). The risk of major bleeding in the aspirin plus VKA group compared with VKA monotherapy tended to increase, without reaching a significant difference (OR 1,41; 95% CI: 0,99-2,01; p=0,06).Conclusion. The addition of aspirin to VKA, compared with VKA monotherapy, reduces the risk of systemic embolism and death in patients after mechanical valve replacement. At the same time, the risk of major bleeding did not differ between the groups.https://russjcardiol.elpub.ru/jour/article/view/4933warfarinvitamin k antagonistaspirinprosthetic mechanical valvethromboembolismbleeding
spellingShingle E. Z. Golukhova
B. Sh. Berdibekov
E. V. Ruzina
Efficacy and safety of combined aspirin and warfarin therapy after heart valve replacement: a systematic review and meta-analysis of randomized clinical trials
Российский кардиологический журнал
warfarin
vitamin k antagonist
aspirin
prosthetic mechanical valve
thromboembolism
bleeding
title Efficacy and safety of combined aspirin and warfarin therapy after heart valve replacement: a systematic review and meta-analysis of randomized clinical trials
title_full Efficacy and safety of combined aspirin and warfarin therapy after heart valve replacement: a systematic review and meta-analysis of randomized clinical trials
title_fullStr Efficacy and safety of combined aspirin and warfarin therapy after heart valve replacement: a systematic review and meta-analysis of randomized clinical trials
title_full_unstemmed Efficacy and safety of combined aspirin and warfarin therapy after heart valve replacement: a systematic review and meta-analysis of randomized clinical trials
title_short Efficacy and safety of combined aspirin and warfarin therapy after heart valve replacement: a systematic review and meta-analysis of randomized clinical trials
title_sort efficacy and safety of combined aspirin and warfarin therapy after heart valve replacement a systematic review and meta analysis of randomized clinical trials
topic warfarin
vitamin k antagonist
aspirin
prosthetic mechanical valve
thromboembolism
bleeding
url https://russjcardiol.elpub.ru/jour/article/view/4933
work_keys_str_mv AT ezgolukhova efficacyandsafetyofcombinedaspirinandwarfarintherapyafterheartvalvereplacementasystematicreviewandmetaanalysisofrandomizedclinicaltrials
AT bshberdibekov efficacyandsafetyofcombinedaspirinandwarfarintherapyafterheartvalvereplacementasystematicreviewandmetaanalysisofrandomizedclinicaltrials
AT evruzina efficacyandsafetyofcombinedaspirinandwarfarintherapyafterheartvalvereplacementasystematicreviewandmetaanalysisofrandomizedclinicaltrials